These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11808457

  • 1. [Life expectancy decreased by 1/3rd. Who to sink the vascular risk of type 2 diabetic patients?].
    MMW Fortschr Med; 2001 Dec 06; 143(49-50):56. PubMed ID: 11808457
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pioglitazone: the future.
    Brunetti P.
    Int J Clin Pract Suppl; 2001 Sep 06; (121):36. PubMed ID: 11594244
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Insulin resistance and atherosclerosis. Controlling diabetes on 2 fronts].
    MMW Fortschr Med; 2003 Sep 11; 145(37):65. PubMed ID: 14584452
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Infarct prevention for diabetics. To lower blood sugar is not enough].
    MMW Fortschr Med; 2001 Nov 15; 143(46):61. PubMed ID: 11759608
    [No Abstract] [Full Text] [Related]

  • 9. [Thiazolidinediones in type 2 diabetes].
    Baum U.
    Med Monatsschr Pharm; 2000 Jul 15; 23(7):210-3. PubMed ID: 10941251
    [No Abstract] [Full Text] [Related]

  • 10. [Objectives and therapeutic strategy in type 2 diabetes mellitus].
    Calvo Romero JM, Lima Rodríguez EM.
    An Med Interna; 2001 Jul 15; 18(7):381-8. PubMed ID: 11534426
    [Abstract] [Full Text] [Related]

  • 11. [New prospects for the type 2 diabetic patient. Delaying disease progression].
    MMW Fortschr Med; 2000 Nov 16; 142(46):56-7. PubMed ID: 11138590
    [No Abstract] [Full Text] [Related]

  • 12. Guidance on rosiglitazone for type 2 diabetes mellitus.
    Matthews DR.
    Lancet; 2001 Feb 10; 357(9254):481. PubMed ID: 11273100
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intensive glucose lowering treatment in type 2 diabetes.
    Preiss D, Ray KK.
    BMJ; 2011 Jul 26; 343():d4243. PubMed ID: 21791496
    [No Abstract] [Full Text] [Related]

  • 15. [Insulin sensitizers is now approved as monotherapy as well. Lowering blood pressure with added effects].
    MMW Fortschr Med; 2003 Oct 09; 145(41):47. PubMed ID: 14655486
    [No Abstract] [Full Text] [Related]

  • 16. Glucose-lowering therapy after myocardial infarction: more questions than answers.
    Radke PW, Schunkert H.
    Eur Heart J; 2008 Jan 09; 29(2):141-3. PubMed ID: 18199566
    [Abstract] [Full Text] [Related]

  • 17. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
    Lehmann DF, Lohray BB.
    J Clin Pharmacol; 2008 Aug 09; 48(8):999-1002. PubMed ID: 18650500
    [No Abstract] [Full Text] [Related]

  • 18. Honing type 2 diabetes treatment.
    Blackburn G.
    Health News; 2001 Jan 09; 7(1):1-2. PubMed ID: 11198405
    [No Abstract] [Full Text] [Related]

  • 19. [Early effect of therapy with pioglitazone. Vascular damage significantly reduced].
    MMW Fortschr Med; 2002 May 23; 144(21):53. PubMed ID: 12134428
    [No Abstract] [Full Text] [Related]

  • 20. [Glitazone--a new class of drugs for the treatment of type 2 diabetes].
    Algenstaedt P, Hamann A.
    Dtsch Med Wochenschr; 2001 Aug 24; 126(34-35):951-2. PubMed ID: 11523019
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.